restenosis

Also found in: Medical, Wikipedia.
Translations

re·ste·no·sis

n. reestenosis, recurrencia de estenosis después de cirugía correctiva.
English-Spanish Medical Dictionary © Farlex 2012

restenosis

n reestenosis f
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive
Background: Currently, drug-eluting balloon (DEB) appears to be an attractive alternative option for the treatment of in-stent restenosis (ISR).
Background: In the era of drug-eluting stents, although bare-metal stent (BMS) remains an option for percutaneous coronary intervention (PCI), restenosis remains the Achilles' heel of BMS implantation.
Along with this occurrence of angiographic restenosis and target vessel revascularization rates were recorded after 3 months of angiographic followup.
Second-generation everolimus-eluting stent for in-stent restenosis (ISR) of drug-eluting stents (DES) is considered as an effective approach although some patients still have recurrences [1].
Although there have been advances in the peripheral stent technology in recent times, the most important issue of the stenting is still in-stent restenosis in long-term follow-up, and its treatment is difficult [3].
Venogram showed restenosis of subclavian vein which was again dilated with the same size balloon.
However, sometimes scar tissue forms inside the stent and impairs blood flow; this is called "in-stent restenosis." Also, although it is rare, blood clots may form inside of stents; to prevent this, it is critical that you take anti-clotting medications exactly as your doctor has prescribed them.
Background and Objective: The risk of restenosis and other adverse cardiovascular events with bare-metal stents have increased with smaller stent diameters and longer stent lengths.
Thus, a mouse model of vascular injury is vitally important for researching the pathophysiological mechanisms to restenosis after percutaneous transluminal coronary angioplasty (PTCA) as well as translational approaches.
M2 EQUITYBITES-April 27, 2017-Mercator MedSystems enrolls first patient under TANGO Trial to assess delivery of a -Limus Agent to prevent BTK Restenosis
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.